EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A review of venous thromboembolism for the hospitalist

Kelly Szymanski iD, Carly Weber, Kaitlin Daugherty, David A Cohen

Postgraduate Medicine · 2025

DOI: 10.1080/00325481.2025.2452155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Postgraduate Medicine, 2025. Verfasst von Kelly Szymanski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA, USA. Hauptthemen laut MEDLINE: Venous Thromboembolism, Anticoagulants, Pulmonary Embolism. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Venous thromboembolism (VTE), consisting of both deep vein thrombosis (DVT) and pulmonary embolism (PE), is an extremely common condition both in the United States and worldwide. Not only is the diagnosis associated with significant morbidity and mortality for patients but it also imposes a deleterious financial burden on the US healthcare system. Diagnosis may be challenging due to variability in clinical presentation and requires a sequential workup including assessment of clinical pretest probability for VTE, D-dimer testing, and imaging. Following diagnosis, proper risk stratification is necessary to determine the appropriate treatment as well as the need for inpatient care. Elucidation of underlying major or minor risk factors at the time of diagnosis is essential as the presence of which may influence the duration of therapy. First-line treatment for most patients is anticoagulation with a direct oral anticoagulant (DOAC) for a minimum of 3-6 months. In multiple clinical trials, DOACs have proven to be non-inferior to vitamin K antagonists for the treatment of VTE with a lower risk of bleeding. Special consideration should be taken in the choice of agent and duration of treatment for patients who have underlying thrombophilias or malignancy and who are pregnant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismAnticoagulantsPulmonary EmbolismHumansHospitalistsRisk FactorsFemaleVenous ThrombosisRisk AssessmentFibrin Fibrinogen Degradation ProductsPregnancy

Stichwörter der Autor:innen

Venous thromboembolismanticoagulationdeep vein thrombosishopsital medicinepulmonary embolism

Substanzen

AnticoagulantsFibrin Fibrinogen Degradation Products

Autor:innen und Institutionen

  • Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA, USA.

ORCID-Profile: Kelly Szymanski

Zitieren

APA

Szymanski, K., Weber, C., Daugherty, K., & Cohen, D. A. (2025). A review of venous thromboembolism for the hospitalist. Postgraduate Medicine. https://doi.org/10.1080/00325481.2025.2452155

Vancouver

Szymanski K, Weber C, Daugherty K, Cohen DA. A review of venous thromboembolism for the hospitalist. Postgraduate Medicine. 2025. doi:10.1080/00325481.2025.2452155

BibTeX
@article{Szymanski2025,
  author = {Szymanski, Kelly and Weber, Carly and Daugherty, Kaitlin and Cohen, David A},
  title = {A review of venous thromboembolism for the hospitalist},
  journal = {Postgraduate Medicine},
  year = {2025},
  doi = {10.1080/00325481.2025.2452155}
}
Kostenlos starten →